This is a concise review of the evaluation and treatment of common etiologies for thrombocytopenia. This presentation will provide participants with an understanding of the complex roles and life cycle of platelets, along with the spectrum of clinical factors that can affect platelet function and physiology.
Presented by Pamiz Alibhai (Alpha Rho)
According to data from the Substance Abuse and Mental Health Services Administration, nearly 1 in 10 US adults have experienced at least 1 major depressive episode. While effective treatments exist in the form of evidence-based psychotherapy and antidepressants, they are limited by access and a lack of novel mechanisms of action, respectively. The purpose of this knowledge-based activity is to review the medications recently approved by the Food and Drug Administration for major depressive disorder and discuss their differences from existing treatment options.
Presented by Kevin Bozymski (Alpha Phi)
This course will provide updates on the management of patients living with HIV, including preferred treatment options, 2-drug regimens, and essential counseling topics.
Presented by Dena Dillon (Alpha)
Participants will learn to comprehensively define their own identities and to more fully appreciate the complex identities of their patients.
Presented by Kate Grafel (Phi)
In 2022, the U.S. Food & Drug Administration approved 38 new chemical entities (NCE's) for marketing. Excluding biological agents (monoclonal antibodies, enzymes, peptides), radiological agents, and imaging contrast agents, 10 small molecule NCE's were approved. The purpose of this knowledge-based activity is to review the chemistry and pharmacology of these agents with a focus on their indication & dosage, pharmacokinetics, adverse effects, contraindications, drug interactions, and other patient counseling information for the pharmacy practitioner.
Presented by Kirk Hevener (Omega)
Presented by Joseph LaRochelle (Iota)
This presentation is designed to provide basic information on veterinary pharmacy practice. Anatomical differences, dosage considerations, legal requirements, resources, and training as they pertain to veterinary pharmacy are just a few of the topics that will be discussed.
The session will be an overview of topics that a pharmacist needs to consider when dispensing veterinary prescriptions and a starting point for veterinary pharmacy practice.
Presented by Thomas Magnifico (Beta Gamma)
Continuous glucose monitoring (CGM) systems, insulin pumps, and glucagon delivery devices are important technologies for diabetes management, but can be confusing for patients and healthcare providers alike. As new devices and updates become available, pharmacists play a crucial role in helping patients navigate these options and choose the best ones for their individual needs. This CE summary provides updates on the latest technologies, including the Dexcom G7, Abbott FreeStyle Libre 3, Tandem t:slim X2, Medtronic MiniMed 770G, glucagon nasal powder, and glucagon autoinjector, as well as the FDA's recent approvals for CGM use in insulin dosing decisions and interoperable insulin pumps. The aim of the CE is to help pharmacists understand how and when to best use these technologies to help and advocate for their patients.
Presented by Jacob Northrup (Gamma Pi) and Bryon Garrety (Beta Beta)
Cultural wisdom is a critical skill for healthcare providers. LCDR Julia Olson will review some of the biases that exist in our healthcare system which reduce our ability to practice culturally responsive care.
Presented by Julia Olson (Alpha Nu)
Presented by Chris Westrick (Alpha Upsilon)